Brief: Sk Biopharmaceuticals To Acquire Shares Worth 62 Billion Won In Proteovant Sciences Inc
30/06/2023 24:46
SK Biopharmaceuticals Co Ltd 326030.KS :
* SK BIOPHARMACEUTICALS: TO ACQUIRE SHARES WORTH 62 BILLION
WON IN
PROTEOVANT SCIENCES INC
Source text for Eikon: ID:
Further company coverage: 326030.KS
Recent news on SK Biopharmaceuticals
See all newsBrief: Sk Biopharmaceuticals Co Signs Licensing-In Contract With 1St Biotherapeutics
US FDA pauses new enrollment in Biohaven's epilepsy drug trials (updated)
US FDA pauses new enrollment in Biohaven's epilepsy drug trials
Biohaven jumps on SK Biopharma epilepsy licensing deal worth up to $795 million
U.S. STOCKS ON THE MOVE-Meta, Kohl's, J.M. Smucker